Clinical Trials Sponsored by Abliva AB

Total 1158 results

RSPR Pharma AB

Completed

Pharmacokinetics of CRD007 in Patients With Abdominal Aorta Aneurisms.

Abdominal Aortic Aneurisms

Denmark
RSPR Pharma AB

Completed

CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)

Abdominal Aortic Aneurysm

Sweden, United Kingdom, Denmark
Moberg Pharma AB

Completed

Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis

Onychomycosis

Sweden
Diamyd Therapeutics AB

Terminated

A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT

Type 1 Diabetes Mellitus

United States
Moberg Pharma AB

Completed

Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp

Seborrhoeic Dermatitis of the Scalp

Sweden
Calliditas Therapeutics AB

Completed

Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)

Post Polio Syndrome, PPS

Sweden
Karolinska Institutet
Vastra Gotaland Region; SOS Alarm Sverige AB; Everdrone AB; Aviation capacity resources... and other collaborators

Completed

AED-delivery Using Drones in Suspected OHCA

Out-Of-Hospital Cardiac Arrest

Sweden
Empros Pharma AB
CTC Clinical Trial Consultants AB

Completed

A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)

Overweight or Obesity

Sweden
Contract Research Organization el AB
Swedish Match AB

Completed

In-vivo Extraction of Pb, Cd andTSNA From Swedish Snus (SMWS03)

Smoking Cessation | Harm Reduction | Smokeless Tobacco

Sweden
Calliditas Therapeutics AB

Recruiting

A Study to Evaluate Setanaxib in Patients With Alport Syndrome

Alport Syndrome

United Kingdom, Spain, Czechia
Melius Pharma AB

Not yet recruiting

Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF) (COSMIC-IPF)

Cough | Idiopathic Pulmonary Fibrosis

India
Exoneural Network AB

Not yet recruiting

The Exopulse Mollii Suit Study - a Database for Routine Follow-up of Clinical Outcomes

Stroke | Multiple Sclerosis | Cerebral Palsy | Spinal Cord Injuries | Neurologic Disorder

Sweden
Hansa Biopharma AB

Recruiting

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children (DINKY)

Kidney Transplantation in Highly Sensitized Patients

Spain, Finland, Sweden
Hansa Biopharma AB

Recruiting

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys (ConfIdeSLTFU)

Kidney Transplantation in Highly Sensitized Patients

United States
Hansa Biopharma AB

Recruiting

A Study With Imlifidase in Anti-GBM Disease (GOOD-IDES-02)

Anti-Glomerular Basement Membrane Disease | Goodpasture Syndrome | Anti-Glomerular Basement Membrane Antibody Disease | Good Pasture Syndrome

United States, Netherlands, Spain, Sweden, United Kingdom, Czechia, Germany, Italy, France, Denmark
BioGaia Pharma AB

Recruiting

A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis

Ulcerative Colitis

Sweden
ABIGO Medical AB

Not yet recruiting

Clinical Investigation of Sorbact® Dressings

Hard-to-heal Wounds | Diabetic Foot Ulcer | Venous Leg Ulcer | Pressure Ulcer | Arterial Leg Ulcer
Hansa Biopharma AB

Recruiting

Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx (ConfIdeS)

Kidney Transplantation in Highly Sensitized Patients

United States
Occlutech International AB

Recruiting

The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

Heart Failure

France, Germany
Lokon Pharma AB

Recruiting

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

Pancreatic Cancer

United States
Guard Therapeutics AB

Terminated

Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery (AKITA)

Acute Kidney Injury

Spain, United States, Germany, Canada, Czechia
Moberg Pharma AB

Completed

Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design (CIPT)

Erythema

United States
Gedea Biotech AB

Completed

Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis (EpHect)

Vulvovaginal Candidiasis

Sweden
Occlutech International AB

Completed

Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus

Patent Ductus Arteriosus

Malaysia, Vietnam
AB Biotics, SA

Completed

Impact of a Probiotic-based Formula on Digestive Symptoms and Mood in Ultra Marathon Runners (AB-ULTRA)

Signs and Symptoms

Spain
Vicore Pharma AB

Completed

First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

Idiopathic Pulmonary Fibrosis | Pulmonary Hypertension | Tolerance | Safety Issues

Sweden
Galecto Biotech AB

Completed

RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients

Idiopathic Pulmonary Fibrosis

United Kingdom
Isofol Medical AB

Completed

A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer (AGENT)

Colo-rectal Cancer

United States, Australia, Austria, Canada, France, Germany, Greece, Japan, Spain, Sweden
Occlutech International AB

Active, not recruiting

The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO (PROOF)

Stroke | PFO - Patent Foramen Ovale

France, Germany, Italy, Canada
Karo Pharma AB

Completed

Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis

Onychomycosis

Tunisia
Karo Pharma AB

Completed

Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.

Chickenpox

Poland
Vicore Pharma AB

Completed

A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes

Endothelial Dysfunction | Type2diabetes

Sweden
Attgeno AB
Vinnova

Withdrawn

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension

COVID-19 | Pulmonary Hypertension

Sweden
AB Biotics, SA

Completed

Evaluation of the Vaginal Colonization of Two New Lactobacillus Strains After Oral Administration in Healthy Volunteers

Healthy

Spain
Karo Pharma AB

Completed

Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms

Vulvovaginal Candidiasis

Poland
AnaMar AB
Covance

Completed

Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects

Tolerability | Safety

United Kingdom
Alligator Bioscience AB

Completed

Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017

Neoplasms | Solid Tumor

Sweden
NextCell Pharma Ab

Active, not recruiting

Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes

Type1diabetes

Sweden
Karo Pharma AB

Completed

Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts

Plantar Wart | Common Wart

Poland
Active Biotech AB

Active, not recruiting

A Study of Laquinimod Eye-drops in Healthy Participants

Eye Diseases

Austria
Diamyd Medical AB

Completed

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes

Glucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic Disease | Vitamin D | Autoimmune Diabetes | Physiological Effects of Drugs | Juvenile Diabetes | Insulin Dependent Diabetes

Czechia, Netherlands, Spain, Sweden
Alteco Medical AB

Withdrawn

Remove LPS Registry

Suspected or Diagnosed Endotoxemia Casued by Gram-negative Bacteria
Viiral Nordic AB

Completed

A Post-Market Clinical Follow-up Investigation to Verify Performance and Safety of Viiral®Nasal Spray in Subjects With Dry Nose Symptoms

Rhinitis Sicca

Sweden
Occlutech International AB

Completed

The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients (PRELIEVE)

Heart Failure | Heart Failure Low Output

Germany, Turkey, Belgium
Gedea Biotech AB

Completed

Clinical Performance and Safety of the Gedea Pessary in Adult Women With Bacterial Vaginosis (Nefertiti)

Bacterial Vaginosis

United Kingdom, Sweden
Karo Pharma AB

Completed

Single Arm Study of Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis

Bacterial Vaginosis

Poland
Alligator Bioscience AB

Completed

Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015

Neoplasms | Solid Tumor

Denmark, Sweden
Calliditas Therapeutics AB

Completed

Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.

Primary Biliary Cirrhosis

United States, Israel, Belgium, Germany, United Kingdom, Spain, Greece, Canada, Italy
Karo Pharma AB

Completed

Hemoclin Gel for the Treatment of Hemorrhoids

Hemorrhoids Grade I and II

Poland
Vicore Pharma AB

Completed

Retrospective Evaluation of Lung Pathology in Subjects With COVID-19 (ATTRACT-2)

Covid19

India

3

Subscribe